DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $19,271,000 | -28.7% | 2,805,045 | 0.0% | 0.51% | -12.9% |
Q1 2022 | $27,041,000 | -18.9% | 2,805,045 | 0.0% | 0.59% | +0.3% |
Q4 2021 | $33,352,000 | -26.8% | 2,805,045 | 0.0% | 0.59% | -6.8% |
Q3 2021 | $45,554,000 | -22.8% | 2,805,045 | 0.0% | 0.63% | -33.4% |
Q2 2021 | $59,018,000 | +35.5% | 2,805,045 | 0.0% | 0.95% | +44.1% |
Q1 2021 | $43,562,000 | -26.0% | 2,805,045 | 0.0% | 0.66% | -20.2% |
Q4 2020 | $58,906,000 | +4.0% | 2,805,045 | 0.0% | 0.82% | -20.6% |
Q3 2020 | $56,634,000 | – | 2,805,045 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |